The Organ Transplant Crisis

Every day, 17 people in the United States die waiting for an organ transplant. There are over 100,000 people on the national transplant waiting list, and the gap between supply and demand grows wider every year. In 2025, fewer than 50,000 organ transplants were performed in the US — meaning less than half the people who needed an organ received one.

The fundamental problem is not just that there are not enough organs. It is that the organs we do have often cannot reach the people who need them. The current standard for organ preservation — cold storage on ice — keeps organs viable for only 4 to 6 hours. This means organs can only be transported within a limited geographic radius, and matching between donors and recipients is constrained by proximity rather than compatibility.

The organ transplant crisis is not a shortage of generosity. It is a shortage of time.

How Organ Supercooling Works

Supercooling is a process that cools organs below the freezing point of water without forming ice crystals. Water normally freezes at 0°C (32°F), but pure water can be cooled well below this temperature if it is free of impurities and container surfaces that would trigger ice nucleation. When ice forms inside cells, it expands and ruptures cell membranes, destroying the organ. Supercooling avoids this entirely by keeping the water in a liquid state at temperatures where metabolic processes nearly stop.

The process works as follows:

The key breakthrough by MIT and Texas A&M was demonstrating that this process works reliably for kidneys — one of the most commonly transplanted organs — and that the kidneys function normally after 72 hours of supercooled storage.

Why 72 Hours Changes Everything

The jump from 4 hours to 72 hours is not just an improvement — it is a transformation. Here is why:

International Transport

With 72-hour preservation, organs can be shipped anywhere in the world. A kidney from a donor in New York could reach a recipient in Tokyo. A liver from London could reach a patient in Lagos. The geographic constraints that currently limit matching would essentially disappear.

Better Matching

Organ matching is currently limited by time and distance. With more time, doctors can perform more detailed compatibility testing, reducing the risk of rejection and improving long-term outcomes. HLA matching, crossmatch testing, and viral screening all take time that the current 4-hour window does not allow.

Reduced Waste

Many organs are currently discarded because they cannot reach a suitable recipient in time. The United Network for Organ Sharing (UNOS) reports that approximately 20% of recovered organs are discarded, often due to logistical constraints rather than quality issues. Supercooling could dramatically reduce this waste.

Living Donation Safety

For living donors, the current process requires the donor and recipient to be in the same hospital at the same time, with both surgeries happening simultaneously. Supercooling would allow the donor surgery to happen first, with the organ stored while the recipient is prepared, reducing risk and complexity for both parties.

History of Organ Preservation

The history of organ preservation is a story of incremental improvements that have now reached a breakthrough point:

The Supercooling Device

The device developed by the MIT/Texas A&M team is a compact, portable system that maintains the supercooled state during storage and transport. Key features include:

The device is not yet commercially available, but the researchers have filed patents and are working with the FDA to begin clinical trials. If approved, it could be available for clinical use within 3-5 years.

The Xenotransplantation Parallel

Supercooling is not the only approach to solving the organ shortage. Xenotransplantation — transplanting organs from animals (typically pigs) into humans — has also seen remarkable progress. In 2025, the first pig kidney transplants into living human patients showed promising short-term results.

However, xenotransplantation faces unique challenges: immune rejection, the risk of animal-to-human disease transmission, and ethical concerns about genetically modifying animals. Supercooling offers a complementary approach that works with human organs, avoiding these issues entirely.

The most likely future is one where both approaches are used: supercooling extending the viability of human organs, and xenotransplantation providing additional supply when human organs are unavailable.

Economic Impact

The economic implications of organ supercooling are substantial:

What Happens Next

The path from laboratory success to clinical implementation involves several steps:

FDA approval — The supercooling device and preservation solution will need to go through the FDA approval process, which typically takes 3-5 years for Class III medical devices. The researchers have already begun preclinical discussions with the agency.

Clinical trials — Initial clinical trials will likely focus on kidneys, which are the most commonly transplanted organ and have the best understood preservation requirements. If successful, trials will expand to livers, hearts, and lungs.

Infrastructure development — Transplant centers will need to be equipped with supercooling devices and trained staff. This will require investment from hospitals and healthcare systems.

Policy changes — Organ allocation policies may need to be updated to account for the longer preservation times and wider geographic reach enabled by supercooling.

What Can You Do

Sources